The bulk analysis/sequencing techniques were the norm for studying the transcriptome, genome, and other omics before Single Cell Analysis. Due to its benefits over bulk sequencing, single-cell technology has gained favour during the last few years. Within the tissue, cells can occasionally have similar appearances but totally diverse activities. Cells in the tissue sample were bulk sequenced to determine average expression. However, single-cell analysis enables more in-depth examination of cells at the individual level and improves illness prognosis.
Single Cell Analysis is becoming a potent tool in the fight against cancer. Each tumour cell is given a molecular state description, allowing for the investigation of tumour heterogeneity, the cell-type composition of the microenvironment, and cell state transitions that influence therapeutic response, particularly in the setting of immunotherapy. The demand for goods used in single-cell analysis is projected to increase due to the increased incidence of various types of cancer and the expansion of cancer research initiatives.